Category: Cardiac Rhythm Management
Medtronic says it won CE Mark approval in the European Union for its Micra leadless pacemaker.
EBR Systems raises $20 million to propel development and regulatory approval of its wireless cardiac resynchronization therapy device.
Medtronic launches a 1,000-patient registry study of phased radiofrequency ablation using its Gold catheter in treating atrial fibrillation.
Medtronic (NYSE:MDT) today said it's launching a huge registry study of its new phased radiofrequency ablation technique for treating atrial fibrillation, the Gold AF trial.
A study finds that Zoll's LifeVest wearable defibrillator shows promise as a temporary option for patients who must have their ICD removed due to infection and await a new implant.
A new study in the journal Heart Rhythm shows the utility of Zoll Medical's LifeVest wearable defibrillator for a subset of patients who don't start out with the device.
An insurance company asked a federal judge to declare that they don't have to cover Biotronik's $28 million in losses from a pair of lawsuits filed over the implantation of allegedly unnecessary pacemakers.
An insurance company that issued policies to Biotronik wants a federal judge in Oregon to declare that they don't have to cover Biotronik's losses in a pair of lawsuits filed over allegedly unneeded pacemaker implantations.
The FDA grants humanitarian use device status to a micro-pacemaker designed to be implanted in a fetus.
Comparative sizes of fetal
and adult pacemakers.
Click image to enlarge.
Researchers at Children's Hospital Los Angeles and the University of Southern California said the FDA granted humanitarian use device status to the fetal micro-pacemaker they designed.
The FDA's approval of Boston Scientific's Emblem S-ICD prompts Wells Fargo to downgrade St. Jude Medical, saying Boston Scientific is poised to take share in the cardiac rhythm management market.